Genprex
Yahoo Finance • 13 days ago
Genprex files to sell 25M shares of common stock by selling shareholders
* Genprex (NASDAQ:GNPX [https://seekingalpha.com/symbol/GNPX]) filed to sell 25 million common stock. * This prospectus is not an offer to sell these securities. * The company will not receive any proceeds from the sale of ordinary s... Full story
Yahoo Finance • 17 days ago
Curious about the most active stocks on Monday?
Curious about the most active stocks on Monday? Find out which stocks are dominating the market action! [mostactive] TOP MOST ACTIVE STOCKS TICKER CHANGE COMMENT OPEN [https://www.chartmill.com/stock/quote/OPEN/profile] 1.9... Full story
Yahoo Finance • 17 days ago
Let's uncover which stocks are experiencing notable gaps during today's session.
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday. [gap] GAP UP STOCKS TICKER CHANGE COMMENT XAIR [https://www.chartmill.com/stock/quote/XAIR/profile] 88.24%... Full story
Yahoo Finance • 20 days ago
Friday's after hours session: top gainers and losers
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. [postmarket] TODAY'S AFTER HOURS GAINERS TICKER CHANGE COMMENT GTBP [https://www.chartmill.com/stock/quote/GTBP/... Full story
Yahoo Finance • last month
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Incannex Healthcare Inc. 251,290,773 0.6207 0.5522 0.5973 +0.1398 Wester... Full story
Yahoo Finance • last month
Friday's session: gap up and gap down stocks
In today's session, there are notable price gaps in the US markets on Friday. Take a closer look at the stocks that are gap up and gap down. [gap] GAP UP STOCKS TICKER CHANGE COMMENT ELAB [https://www.chartmill.com/stock/quot... Full story
Yahoo Finance • last month
Wondering what's happening in today's pre-market session?
Wondering what's happening in Friday's pre-market session? Find an overview in this article. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT EEIQ [https://www.chartmill.com/stock/quote/EEIQ/profile] 127.0% EPICQUEST... Full story
Yahoo Finance • last month
Stay updated with the stocks that are on the move in today's after-hours session.
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. [postmarket] AFTER HOURS GAINERS TICKER CHANGE COMMENT THAR [https://www.chartmill.com/stock/quote/THAR/profile] 1... Full story
Yahoo Finance • last month
Genprex receives patent allowances for cancer therapy combinations
AUSTIN, Texas - Genprex, Inc. (NASDAQ:GNPX), a clinical-stage gene therapy company with a market capitalization of $7 million, announced Monday that it has received Notices of Allowance for patents covering its lead drug candidate REQORSA... Full story
Yahoo Finance • 2 years ago
IBN Announces Latest Episode of The Bell2Bell Podcast featuring CEO Rodney Varner & CFO Ryan Confer of Genprex, Inc.
LOS ANGELES, July 06, 2023 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The... Full story
Yahoo Finance • 3 years ago
Genprex Receives Safety Review Committee Approval to Proceed to Final Cohort in Acclaim-1 Phase 1 Dose Escalation Trial of REQORSA® in Combination with Tagrisso® in Advanced Non-Small Cell Lung Cancer
Recommendation to Advance to Increased Dose in Third and Final Cohort of Phase 1 Portion of Trial Indicates Favorable Safety Profile of Novel Gene Therapy in Solid Tumor Cancer AUSTIN, Texas, Dec. 14, 2022 /PRNewswire/ -- Genprex, Inc. ("... Full story
Yahoo Finance • 3 years ago
Genprex Announces the Opening for Enrollment of its Phase 1/2 Acclaim-2 Clinical Trial of REQORSA™ Immunogene Therapy in Combination With Keytruda® to Treat Non-Small Cell Lung Cancer
Company Has FDA Fast Track Designation for Combination of REQORSA and Keytruda AUSTIN, Texas, March 31, 2022--(BUSINESS WIRE)--Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on dev... Full story
